Medical Cannabis Rescheduling to Unlock Millions in Tax Deductions
The Administration moved medical cannabis from Schedule I to Schedule III, removing IRS code 280E restrictions and potentially unlocking millions in tax deductions for MSOS ETF holdings. Only medical cannabis qualifies for these deductions before a June DEA hearing on recreational classification, forcing firms to consider strategic shifts in operations.
1. Schedule III Reclassification Details
Last month medical cannabis was reclassified from Schedule I to Schedule III under the Controlled Substances Act, removing its comparison to heroin and qualifying it for standard business deductions, while recreational cannabis awaits a DEA hearing in June.
2. 280E Tax Relief Effects
With the removal of IRS code 280E for medical cannabis sales, cultivators and retailers can now deduct operating expenses, potentially freeing up millions in cash flow for reinvestment or acquisitions across MSOS’s constituent companies.
3. Key ETF Holdings Positioned for Gains
Florida-based Trulieve, controlling over 20% of statewide medical dispensaries, stands to benefit most from new deductions, while other constituents may pivot operations toward medical-only states to maximize tax relief ahead of upcoming earnings calls.